Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7

Leukemia

Volumn 13, Issue 3, 1999, Pages 376-385

  Hasle, H ⁱ   Arico M ^a   Basso, G ^e   Biondi, A ^e   Rajnoldi, A Cantù ^e   Creutzig, U ^e   Fenu, S ^b   Fonatsch, C ^e   Haas, O A ^c   Harbott, J ^d   Kardos, G ^e   Kerndrup, G ^e   Mann, G ^c   Niemeyer, C M ^e   Ptoszkova, H ^e   Ritter, J ^e   Slater, R ^f   Stary J ^g   Stollmann Gibbels, B ^e   Testi, A M ^b   Van Wering, E R ^h   Zimmermann, M ^e   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

^e Department of Pediatrics ^*

^f Netherlands Working Party Cancer G   (Netherlands)

^g 2nd Dept of Pediatrics   (Czech Republic)

^h Dutch Childhood Leukemia Study Group   (Netherlands)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myeloid leukemia (AML); Children; Monosomy 7; Myelodysplastic syndrome (MDS)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHROMOSOME 7; CHROMOSOME DELETION; DISEASE CONTROL; FEMALE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; PARTIAL MONOSOMY; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0033050457     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401342     Document Type: Article

References (68)

1. Hasle H, Kerndrup G, lacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia 1995; 9: 1569-1572.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
4. Hasle H. Myelodysplastic syndromes in childhood. Classification, epidemiology, and treatment. Leuk Lymphoma 1994; 13: 11-26.
5. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessells JM. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742-1750.
6. Haas OA, Gadner H. Pathogenesis, biology, and management of myelodysplastic syndromes in children. Semin Hematol 1996; 33: 225-235.
7. Freedman MH, Estrov Z, Chan HSL. Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 1988; 10: 261-267.
8. Hann IM, Myelodysplastic syndromes. Arch Dis Child 1992; 67: 962-966.
9. Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C, Miller D, Seligmann M, Bernard J. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer 1984; 54: 675-686.
10. Brandwein JM, Horsman DE, Eaves AC, Eaves CJ, Massing BG, Wadsworth LD, Rogers PC, Kalousek DK. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. Am J Pediatr Hematol Oncol 1990; 12: 63-70.
11. Niemeyer CM, Aricò M, Basso G, Cantù-Rajnoldi A, Creutzig U, Haas OA, Harbott J, Hasle H, Kerndrup C, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer Korthof ET, van Wering ER. Zimmermann M, and Members of the European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997; 89: 3534-3543.
12. Iversen PO, Rodwell RL, Pitcher L, Taylor KM, Lopez AF. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 1996; 88: 2634-2639.
13. Emanuel PD, Shannon KM, Castleberry RP. Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Mol Med Today 1996; 2: 468-475.
14. Aricò M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488.
15. Groupe Francais de Cytogénétique Hématologique. Forty-four cases of childhood myelodysplasia with cytogenetics, documented by the Groupe Francais de Cytogénétique Hématologique. Leukemia 1997; 11: 1478-1485.
16. Leverger G, Bernheim A, Daniel MT, Flandrin G, Schaison G, Berger R. Cytogenetic study of 130 childhood acute nonlymphocytic leukemias. Med Pediatr Oncol 1988; 16: 227-232.
17. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro JJ, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
18. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 1995; 86: 3097-3108.
19. Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996; 87: 4979-4989.
20. Sieff CA, Chessells JM, Harvey BA, Pickthall VJ, Lawler SD. Monosomy 7 in childhood: a myeloproliferative disorder. Br J Haematol 1981; 49: 235-249.
21. Cyger M, Bonny Y, Forest L. Childhood monosomy 7 syndrome. Am J Hematol 1982, 13: 329-334.
22. Weiss K, Stass S, Williams D, Kalwinsky D, Dahl GV, Wang W, Johnson FL, Murphy SB, Dow LW. Childhood monosomy 7 syndrome: clinical and in vitro studies. Leukemia 1987; 1: 97-104.
23. Evans JP, Czepulkowski B, Gibbons B, Swansbury GJ, Chessells JM, Childhood monosomy 7 revisited. Br J Haematol 1988; 69: 41-45.
24. Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995; 85: 1985-1999.
25. Locatelli F, Niemeyer C, Angelucci E, Bender-Götze C, Burdach S, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Pession A, Peters C, Schmid HJ, Stary J, Suttorp M, Uderzo C, van't Veer Korthof ET, Vossen J, Zecca M, Zimmermann M. Allogeneic bone marrow transplantation for chronic myelornonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997; 15: 566-573.
26. ISCN (1995). An International System for Human Cytogenetic Nomenclature. Karger: Basel; 1995.
27. Hasle H, Kerndrup G. Atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia in children. Br J Haematol 1995; 89: 428-429.
28. Niemeyer CM, Fenu S, Hasle H, Mann G, Stary J, van Wering ER. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998; 91: 365-367.
29. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R. Gale RP. Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG. Report of the national cancer institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813-819.
30. Dallman PR, Siimes MA. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr 1979; 94: 26-31.
31. Huehns ER, Beaven GH. Developmental changes in human haemoglobins. In: Benson P (ed). The biochemistry of Development. W Heineman Medical Books: London; 1971, pp 175-203.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
33. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
34. Ciampi A, Hogg SA, Kates L. Stratification by stepwise regression, correspondence analysis and recursive partition: a comparison of three methods of analysis for survival data with covariates. Computational Stat Data Analysis 1986; 4: 184-204.
35. Trueworthy R, Shuster J, Look T, Crist W, Borowitz MJ, Carroll A, Frankel L, Harris M, Wagner H, Haggard M, Mosijczuk AD, Pullen J, Steuber P, Land V. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a pediatric oncology group study. J Clin Oncol 1992: 10: 606-613.
36. Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 1996; 88: 1930-1935.
37. Rizzari C, Bacchiocchi D, Rovelli A, Biondi A, Cantù-Rajnoldi A, Uderzo C, Masera G. Myelodysplastic syndrome in a child with Rothmund-Thomson syndrome: a case report. J Pediatr Hematol Oncol 1996; 18: 96-97.
38. Stollmann B, Fonatsch C, Havers W. Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. Br J Haematol 1985: 60: 183-196.
39. Chan GCF, Wang W, Head D, Krance R, Chen G, Raimondi SC. Childhood monosomy 7: a clinical review of 25 cases in a single institution. Blood 1995; 86 (Suppl 1): 51a (Abstr.).
40. Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 1996; 94: 82-88.
41. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-2195.
42. Ruutu P, Ruutu T, Repo H, Vuopio P, Timonen T, Kosunen TU, de la Chapelle A. Defective neutrophil migration in monosomy 7. Blood 1981; 58: 739-745.
43. Hasle H, Kerndrup G, Yssing M, Clausen N, Østergaard E, Jacobsen N, Jacobsen BB. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996; 10: 1269-1273.
44. Flactif M, Lai JL, Preudhomme C, Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 1994; 8: 1012-1018.
45. Viguié F, Prigent Y, Ramond S, Baumelou E, Cadiou M, Dreyfus F, Zittoun R. Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7. Leukemia 1995; 9: 1154-1158.
46. Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Blondi A, Scherer SW, Kearney L. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH). Leukemia 1996; 10: 644-649.
47. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersey JH, Feig S, Bernstein I, Hammond D, the Children's Cancer Study Group. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 1985; 3: 3-11.
48. Groupe Francais de Cytogénétique Hématologique. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosome abnormalities. Cancer Genet Cytogenet 1988; 35: 243-252.
49. Bunin N, Nowell PC, Belasco J, Shah N, Willoughby M, Farber PA, Lange B. Chromosome 7 abnormalities in children with Down syndrome and preleukemia. Cancer Genet Cytogenet 1991; 54: 119-126.
50. Zipursky A, Wang H, Brown EJ, Squire J. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome. Blood 1994; 84: 2278-2282.
51. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann Gibbels B, Zimmermann M, Harbott J. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 1996; 10: 1677-1686.
52. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: children's cancer group studies 2861 and 2891. Blood 1998; 91: 608-615.
53. Mori PG, Haupt R, Fugazza G, Sessarego M, Corcione A, Strigini P, Sansone R. Pentasomy 21 in leukemia complicating Diamond-Blackfan anemia. Cancer Genet Cytogenet 1992; 63: 70-72.
54. Kotzot D, Schmitt S, Bernasconi F, Robinson WP, Lurie IW, Ilyna H, Mehes K, Hamel BCJ. Otten BJ, Hergerberg M, Werder E, Schoenle E, Schinzel A. Uniparental disomy 7 in Silver-Russel syndrome and primordial growth retardation. Hum Mol Genet 1995; 4: 583-587.
55. Carroll WL, Morgan R, Glader BE. Childhood bone marrow monosomy 7 syndrome: a familial disorder? J Pediatr 1985; 107: 578-580.
56. Shannon KM, Turhan AG, Chang SS, Bowcock AM, Rogers PC, Carroll WL, Cowan MJ, Glader BE, Eaves CJ, Eaves AC, Kan YW. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 1989; 84: 984-989.
57. Gilchrist DM, Friedman JM, Rogers PC, Creighton SP. Myelodysplasia and leukemia syndrome with monosomy 7: a genetic perspective. Am J Med Genet 1990; 35: 437-441.
58. Hasle H, Olsen JH. Cancer in relatives of children with myelod-ysplastic syndrome, acute and chronic myeloid leukaemia. Br J Haematol 1997; 97: 127-131.
59. Mijovic A, Antunovic P, Pagliuca A, Mufti GJ. Familial myelodysplastic syndromes: a key to understanding leukaemogenesis? Leukemia Res 1997; 21(Suppl. 1): S6 (Abstr.).
60. Hasle H, Olsen JH, Hansen J, Friedrich U, Tommerup N. Occurrence of cancer in a cohort of 183 persons with constitutional chromosome 7 abnormalities. Cancer Genet Cytogenet 1998; 105: 39-42.
61. Scheurlen W, Borkhardt A, Ritterbach J, Huppertz HI. Spontaneous hematological remission in a boy with myelodysplastic syndrome and monosomy 7. Leukemia 1994; 8: 1435-1438.
62. Benaim E, Hvizdala EV, Papenhausen P, Moscinski LC. Spotaneous remission in monosomy 7 myelodysplastic syndrome. Br J Haematol 1995; 89: 947-948.
63. Renneboog B, Hansen V, Heirnann P, De Mulder A, Jannsen F, Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 1996; 92: 696-698.
64. Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL. Thomas C, Lyonnet S, Lavergne JM, Dommergues JP. Occurrence of myeloproliferative disorders in patients with Noonan syndrome. J Pediatr 1997; 130: 885-889.
65. Creutzig U, Bender-Götze C, Ritter J, Zimmermann M. Stollmann-Gibbels B, Körholz D, Niemeyer C. The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-T. Leukemia 1998; 12: 652-659.
66. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
67. Kalra R, Paderanga DC, Olson K, Shannon KM. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 1994; 84: 3435-3439.
68. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. New Engl J Med 1994; 330: 597-601.